The Roles of MicroRNAs in Obesity: Emphasizing Links with Chronic Kidney Disease and Cardiovascular Disorders
Abstract
:1. Obesity as a Global Health Challenge
2. MicroRNAs: An Overview of Regulatory Molecules
2.1. Biogenesis of miRNAs
2.2. miRNA Function
3. MicroRNAs in Obesity
3.1. MicroRNAs and Adipose Tissue Development
3.2. MicroRNAs in Energy Homeostasis and Metabolic Pathways
3.3. Role of MicroRNAs in Inflammation and Insulin Resistance
4. MicroRNAs’ Roles in the Link between Obesity and CKD
5. MicroRNAs in Obesity-Associated Cardiovascular Risk Factors
5.1. MicroRNAs in Endothelial Dysfunction and Atherosclerosis
5.2. MicroRNAs in Cardiac Remodeling and Dysfunction
6. MicroRNAs as Biomarkers for Obesity-Related Diseases
7. MicroRNAs in Sarcopenia: A Direct Link between CKD and Obesity?
8. Targeting MicroRNAs for Therapeutic Interventions: Challenges and Future Perspectives
9. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Endalifer, M.L.; Diress, G. Epidemiology, Predisposing Factors, Biomarkers, and Prevention Mechanism of Obesity: A Systematic Review. J. Obes. 2020, 2020, 6134362. [Google Scholar] [CrossRef] [PubMed]
- Popkin, B.M.; Adair, L.S.; Ng, S.W. Global Nutrition Transition and the Pandemic of Obesity in Developing Countries. Nutr. Rev. 2012, 70, 3–21. [Google Scholar] [CrossRef] [PubMed]
- Gai, Z.; Wang, T.; Visentin, M.; Kullak-Ublick, G.A.; Fu, X.; Wang, Z. Lipid Accumulation and Chronic Kidney Disease. Nutrients 2019, 11, 722. [Google Scholar] [CrossRef] [PubMed]
- Macêdo, A.P.A.; Vieira, R.F.L.; Brisque, G.D.; Abud, G.F.; Pauli, J.R. Liraglutide and Exercise: A Possible Treatment for Obesity? Obesities 2022, 2, 285–291. [Google Scholar] [CrossRef]
- Souza, A.R.; Bandeira, P.F.R.; Da Silva, M.A.C.; Da Cunha, G.L.; Pereira, D.F.; Martins, C. Twenty-Four-Hour Movement Behaviors, Fitness, and Adiposity in Preschoolers: A Network Analysis. Obesities 2023, 3, 36–45. [Google Scholar] [CrossRef]
- Macêdo, A.P.A.; Gonçalves, M.D.S.; Barreto-Medeiros, J.M.; Da Silva Neto, O.C.; David, J.M.; Villarreal, C.F.; Macambira, S.G.; Pereira Soares, M.B.; Couto, R.D. Green Tea Induces the Browning of Adipose Tissue—Systematic Review. Obesities 2023, 3, 193–206. [Google Scholar] [CrossRef]
- Bartel, D.P. MicroRNAs: Target Recognition and Regulatory Functions. Cell 2009, 136, 215–233. [Google Scholar] [CrossRef] [PubMed]
- Metzinger-Le Meuth, V.; Metzinger, L. miR-223 and Other miRNA’s Evaluation in Chronic Kidney Disease: Innovative Biomarkers and Therapeutic Tools. Non-Coding RNA Res. 2019, 4, 30–35. [Google Scholar] [CrossRef]
- Guo, H.; Ingolia, N.T.; Weissman, J.S.; Bartel, D.P. Mammalian microRNAs Predominantly Act to Decrease Target mRNA Levels. Nature 2010, 466, 835–840. [Google Scholar] [CrossRef]
- Metzinger-Le Meuth, V.; Burtey, S.; Maitrias, P.; Massy, Z.A.; Metzinger, L. microRNAs in the Pathophysiology of CKD-MBD: Biomarkers and Innovative Drugs. Biochim. Biophys. Acta Mol. Basis Dis. 2017, 1863, 337–345. [Google Scholar] [CrossRef]
- Agbu, P.; Carthew, R.W. MicroRNA-Mediated Regulation of Glucose and Lipid Metabolism. Nat. Rev. Mol. Cell Biol. 2021, 22, 425–438. [Google Scholar] [CrossRef] [PubMed]
- Nazari, M.; Saberi, A.; Karandish, M.; Neisi, N.; Jalali, M.T.; Makvandi, M. Influence of L-Carnitine on the Expression Level of Adipose Tissue miRNAs Related to Weight Changes in Obese Rats. Pak. J. Biol. Sci. 2016, 19, 227–232. [Google Scholar] [CrossRef] [PubMed]
- Wang, T.; Li, M.; Guan, J.; Li, P.; Wang, H.; Guo, Y.; Shuai, S.; Li, X. MicroRNAs miR-27a and miR-143 Regulate Porcine Adipocyte Lipid Metabolism. Int. J. Mol. Sci. 2011, 12, 7950–7959. [Google Scholar] [CrossRef] [PubMed]
- Arias, N.; Aguirre, L.; Fernández-Quintela, A.; González, M.; Lasa, A.; Miranda, J.; Macarulla, M.T.; Portillo, M.P. MicroRNAs Involved in the Browning Process of Adipocytes. J. Physiol. Biochem. 2016, 72, 509–521. [Google Scholar] [CrossRef] [PubMed]
- Goody, D.; Pfeifer, A. MicroRNAs in Brown and Beige Fat. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 2019, 1864, 29–36. [Google Scholar] [CrossRef]
- Rodó, J.; Garcia, M.; Casana, E.; Muñoz, S.; Jambrina, C.; Sacristan, V.; Franckhauser, S.; Grass, I.; Jimenez, V.; Bosch, F. Integrated Gene Expression Profiles Reveal a Transcriptomic Network Underlying the Thermogenic Response in Adipose Tissue. Sci. Rep. 2023, 13, 7266. [Google Scholar] [CrossRef]
- Lewis, A.P.; Jopling, C.L. Regulation and Biological Function of the Liver-Specific miR-122. Biochem. Soc. Trans. 2010, 38, 1553–1557. [Google Scholar] [CrossRef] [PubMed]
- Nie, H.; Song, C.; Wang, D.; Cui, S.; Ren, T.; Cao, Z.; Liu, Q.; Chen, Z.; Chen, X.; Zhou, Y. MicroRNA-194 Inhibition Improves Dietary-Induced Non-Alcoholic Fatty Liver Disease in Mice through Targeting on FXR. Biochim. Biophys. Acta Mol. Basis Dis. 2017, 1863, 3087–3094. [Google Scholar] [CrossRef]
- Xu, R.-H.; Liu, B.; Wu, J.-D.; Yan, Y.-Y.; Wang, J.-N. miR-143 Is Involved in Endothelial Cell Dysfunction through Suppression of Glycolysis and Correlated with Atherosclerotic Plaques Formation. Eur. Rev. Med. Pharmacol. Sci. 2016, 20, 4063–4071. [Google Scholar]
- Vandanmagsar, B.; Youm, Y.-H.; Ravussin, A.; Galgani, J.E.; Stadler, K.; Mynatt, R.L.; Ravussin, E.; Stephens, J.M.; Dixit, V.D. The NLRP3 Inflammasome Instigates Obesity-Induced Inflammation and Insulin Resistance. Nat. Med. 2011, 17, 179–188. [Google Scholar] [CrossRef]
- Duan, Q.; Mao, X.; Xiao, Y.; Liu, Z.; Wang, Y.; Zhou, H.; Zhou, Z.; Cai, J.; Xia, K.; Zhu, Q.; et al. Super Enhancers at the miR-146a and miR-155 Genes Contribute to Self-Regulation of Inflammation. Biochim. Biophys. Acta 2016, 1859, 564–571. [Google Scholar] [CrossRef] [PubMed]
- Chakraborty, C.; Doss, C.G.P.; Bandyopadhyay, S.; Agoramoorthy, G. Influence of miRNA in Insulin Signaling Pathway and Insulin Resistance: Micro-Molecules with a Major Role in Type-2 Diabetes. Wiley Interdiscip. Rev. RNA 2014, 5, 697–712. [Google Scholar] [CrossRef] [PubMed]
- Virtue, A.; Johnson, C.; Lopez-Pastraña, J.; Shao, Y.; Fu, H.; Li, X.; Li, Y.-F.; Yin, Y.; Mai, J.; Rizzo, V.; et al. MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-Alcoholic Fatty Liver Disease: A Novel Mouse Model of Obesity Paradox. J. Biol. Chem. 2017, 292, 1267–1287. [Google Scholar] [CrossRef] [PubMed]
- Maitrias, P.; Metzinger-Le Meuth, V.; Nader, J.; Reix, T.; Caus, T.; Metzinger, L. The Involvement of miRNA in Carotid-Related Stroke. Arterioscler. Thromb. Vasc. Biol. 2017, 37, 1608–1617. [Google Scholar] [CrossRef]
- Peters, L.J.F.; Floege, J.; Biessen, E.A.L.; Jankowski, J.; van der Vorst, E.P.C. MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application. Int. J. Mol. Sci. 2020, 21, 6547. [Google Scholar] [CrossRef]
- Fourdinier, O.; Glorieux, G.; Brigant, B.; Diouf, M.; Pletinck, A.; Vanholder, R.; Choukroun, G.; Verbeke, F.; Massy, Z.A.; Metzinger-Le Meuth, V.; et al. Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease. Int. J. Mol. Sci. 2021, 22, 10549. [Google Scholar] [CrossRef]
- Sun, L.; Zhang, D.; Liu, F.; Xiang, X.; Ling, G.; Xiao, L.; Liu, Y.; Zhu, X.; Zhan, M.; Yang, Y.; et al. Low-Dose Paclitaxel Ameliorates Fibrosis in the Remnant Kidney Model by down-Regulating miR-192. J. Pathol. 2011, 225, 364–377. [Google Scholar] [CrossRef]
- Nader, J.; Metzinger, L.; Maitrias, P.; Caus, T.; Metzinger-Le Meuth, V. Aortic Valve Calcification in the Era of Non-Coding RNAs: The Revolution to Come in Aortic Stenosis Management? Non-Coding RNA Res. 2020, 5, 41–47. [Google Scholar] [CrossRef]
- Gimbrone, M.A.; García-Cardeña, G. Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis. Circ. Res. 2016, 118, 620–636. [Google Scholar] [CrossRef]
- Donghui, T.; Shuang, B.; Xulong, L.; Meng, Y.; Yujing, G.; Yujie, H.; Juan, L.; Dongsheng, Y. Improvement of Microvascular Endothelial Dysfunction Induced by Exercise and Diet Is Associated with microRNA-126 in Obese Adolescents. Microvasc. Res. 2019, 123, 86–91. [Google Scholar] [CrossRef]
- Bassand, K.; Metzinger, L.; Naïm, M.; Mouhoubi, N.; Haddad, O.; Assoun, V.; Zaïdi, N.; Sainte-Catherine, O.; Butt, A.; Guyot, E.; et al. miR-126-3p Is Essential for CXCL12-Induced Angiogenesis. J. Cell. Mol. Med. 2021, 25, 6032–6045. [Google Scholar] [CrossRef] [PubMed]
- Fourdinier, O.; Schepers, E.; Metzinger-Le Meuth, V.; Glorieux, G.; Liabeuf, S.; Verbeke, F.; Vanholder, R.; Brigant, B.; Pletinck, A.; Diouf, M.; et al. Serum Levels of miR-126 and miR-223 and Outcomes in Chronic Kidney Disease Patients. Sci. Rep. 2019, 9, 4477. [Google Scholar] [CrossRef] [PubMed]
- Nader, J.; Metzinger-Le Meuth, V.; Maitrias, P.; Humbert, J.-R.; Brigant, B.; Tribouilloy, C.; Metzinger, L.; Caus, T. miR-92a: A Novel Potential Biomarker of Rapid Aortic Valve Calcification. J. Heart Valve Dis. 2017, 26, 327–333. [Google Scholar] [PubMed]
- de Franciscis, S.; Metzinger, L.; Serra, R. Roles and Clinical Applications of Biomarkers in Cardiovascular Disease. BioMed Res. Int. 2016, 2016, 8982796. [Google Scholar] [CrossRef] [PubMed]
- de Toledo Frias, F.; de Mendonça, M.; Martins, A.R.; Gindro, A.F.; Cogliati, B.; Curi, R.; Rodrigues, A.C. MyomiRs as Markers of Insulin Resistance and Decreased Myogenesis in Skeletal Muscle of Diet-Induced Obese Mice. Front. Endocrinol. 2016, 7, 76. [Google Scholar] [CrossRef]
- Dorn, G.W.; Matkovich, S.J.; Eschenbacher, W.H.; Zhang, Y. A Human 3′ miR-499 Mutation Alters Cardiac mRNA Targeting and Function. Circ. Res. 2012, 110, 958–967. [Google Scholar] [CrossRef] [PubMed]
- Xiao, J.; Shen, B.; Li, J.; Lv, D.; Zhao, Y.; Wang, F.; Xu, J. Serum microRNA-499 and microRNA-208a as Biomarkers of Acute Myocardial Infarction. Int. J. Clin. Exp. Med. 2014, 7, 136–141. [Google Scholar]
- Scolari, F.L.; Faganello, L.S.; Garbin, H.I.; Piva E Mattos, B.; Biolo, A. A Systematic Review of microRNAs in Patients with Hypertrophic Cardiomyopathy. Int. J. Cardiol. 2021, 327, 146–154. [Google Scholar] [CrossRef]
- Roberts, T.C.; Coenen-Stass, A.M.L.; Wood, M.J.A. Assessment of RT-qPCR Normalization Strategies for Accurate Quantification of Extracellular microRNAs in Murine Serum. PLoS ONE 2014, 9, e89237. [Google Scholar] [CrossRef]
- Lv, L.-L.; Cao, Y.-H.; Ni, H.-F.; Xu, M.; Liu, D.; Liu, H.; Chen, P.-S.; Liu, B.-C. MicroRNA-29c in Urinary Exosome/Microvesicle as a Biomarker of Renal Fibrosis. Am. J. Physiol. Ren. Physiol. 2013, 305, F1220–F1227. [Google Scholar] [CrossRef]
- Han, R.; Hu, S.; Qin, W.; Shi, J.; Zeng, C.; Bao, H.; Liu, Z. Upregulated Long Noncoding RNA LOC105375913 Induces Tubulointerstitial Fibrosis in Focal Segmental Glomerulosclerosis. Sci. Rep. 2019, 9, 716. [Google Scholar] [CrossRef] [PubMed]
- Zhou, S.-S.; Jin, J.-P.; Wang, J.-Q.; Zhang, Z.-G.; Freedman, J.H.; Zheng, Y.; Cai, L. miRNAS in Cardiovascular Diseases: Potential Biomarkers, Therapeutic Targets and Challenges. Acta Pharmacol. Sin. 2018, 39, 1073–1084. [Google Scholar] [CrossRef]
- Lu, D.; Thum, T. RNA-Based Diagnostic and Therapeutic Strategies for Cardiovascular Disease. Nat. Rev. Cardiol. 2019, 16, 661–674. [Google Scholar] [CrossRef] [PubMed]
- Barreto Silva, M.I.; Picard, K.; Klein, M.R.S.T. Sarcopenia and Sarcopenic Obesity in Chronic Kidney Disease: Update on Prevalence, Outcomes, Risk Factors and Nutrition Treatment. Curr. Opin. Clin. Nutr. Metab. Care 2022, 25, 371–377. [Google Scholar] [CrossRef] [PubMed]
- Torella, D.; Iaconetti, C.; Catalucci, D.; Ellison, G.M.; Leone, A.; Waring, C.D.; Bochicchio, A.; Vicinanza, C.; Aquila, I.; Curcio, A.; et al. MicroRNA-133 Controls Vascular Smooth Muscle Cell Phenotypic Switch in Vitro and Vascular Remodeling in Vivo. Circ. Res. 2011, 109, 880–893. [Google Scholar] [CrossRef]
- Matkovich, S.J.; Wang, W.; Tu, Y.; Eschenbacher, W.H.; Dorn, L.E.; Condorelli, G.; Diwan, A.; Nerbonne, J.M.; Dorn, G.W. MicroRNA-133a Protects against Myocardial Fibrosis and Modulates Electrical Repolarization without Affecting Hypertrophy in Pressure-Overloaded Adult Hearts. Circ. Res. 2010, 106, 166–175. [Google Scholar] [CrossRef]
- Paunovska, K.; Loughrey, D.; Dahlman, J.E. Drug Delivery Systems for RNA Therapeutics. Nat. Rev. Genet. 2022, 23, 265–280. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Metzinger-Le Meuth, V.; Metzinger, L. The Roles of MicroRNAs in Obesity: Emphasizing Links with Chronic Kidney Disease and Cardiovascular Disorders. Obesities 2023, 3, 243-252. https://doi.org/10.3390/obesities3030020
Metzinger-Le Meuth V, Metzinger L. The Roles of MicroRNAs in Obesity: Emphasizing Links with Chronic Kidney Disease and Cardiovascular Disorders. Obesities. 2023; 3(3):243-252. https://doi.org/10.3390/obesities3030020
Chicago/Turabian StyleMetzinger-Le Meuth, Valérie, and Laurent Metzinger. 2023. "The Roles of MicroRNAs in Obesity: Emphasizing Links with Chronic Kidney Disease and Cardiovascular Disorders" Obesities 3, no. 3: 243-252. https://doi.org/10.3390/obesities3030020